Actively Recruiting
Randomized, Double-Blind Study of LHP588 Versus Placebo in Adults With P. Gingivalis-Positive Alzheimers Disease
Led by Lighthouse Pharmaceuticals, Inc. · Updated on 2026-10-07
300
Participants Needed
39
Research Sites
6 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the drug LHP588 in individuals aged 55 to 80 years who have mild to moderate Alzheimers disease AD and a confirmed infection with the bacterium P. gingivalis Pg. The study explores whether targeting this bacterium can slow or stop the progression of AD symptoms. Participants must have shown progressive cognitive decline in the past year, and the diagnosis is confirmed using standard criteria and tests including MMSE and plasma pTau217 levels. The study is a randomized, double-blind, placebo-controlled trial where participants are assigned to one of three groups receiving either 25 mg or 50 mg of LHP588 or placebo once daily for 48 weeks. The treatment period includes a 2-week dose escalation for the higher dose group. Before treatment, participants undergo a screening period lasting up to 12 weeks to confirm eligibility, including saliva tests for Pg infection and brain MRI to rule out other causes of dementia. After treatment, a 4-week safety follow-up monitors participants health. During the study, participants and their caregivers will visit the study center at least 20 times over about 64 weeks. Assessments include cognitive and functional tests like ADAS-Cog, ADCS-ADL, CMAI, and CDR-SB, as well as physical exams, blood tests for pharmacokinetics and biomarkers, saliva tests for Pg infection, ECGs, and safety labs. A phone call will also be made during the safety follow-up. The main outcome measured is change in cognitive function using ADAS-Cog11 between weeks 40 and 48.
CONDITIONS
Brief Title
Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
Research Team
J
Joanna Bolger
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here